| 1000 blog results |
|
-
Contributor: Yali Friedman
Contributor: 05/18/2013 12:00:00 AM EDT
Singapore’s biomedical science sector development strategy: Is it sustainable? Copyright © thinkBiotech This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology Singapore's biomedical science sector development strategy: Is it sustainable? Go to paperABSTRACT: This paper outlines the strategic efforts undertaken by. read more
-
Contributor: Yali Friedman
Contributor: 05/18/2013 12:00:00 AM EDT
Drug Patent Expirations for May 18 2013 Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.com/innovation to see the latest expirations Advertise here This newsletter is a free service of DrugPatentWatch DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents Drug Patent Expirations for May 18 2013 Tradename Applicant Generic Name Patent Expiration OSMOPREP Salix Pharms sodium phosphate, dibasic, anhydrous; sodium phosphate, read more
-
Contributor: Yali Friedman
Contributor: 05/15/2013 12:00:00 AM EDT
Introducing BiologicPatentWatch: Biotechnology Industry Competitive Intelligence Copyright © thinkBiotech After months of development, BiologicPatentWatch.com is live. Building on the framework of DrugPatentWatch, BiologicPatentWatch provides comprehensive details on FDA approved biologic drugs, developers and patents. read more
-
Contributor: Yali Friedman
Contributor: 05/14/2013 12:00:00 AM EDT
Drug Patent Expirations for May 14 2013 Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.com/innovation to see the latest expirations Advertise here This newsletter is a free service of DrugPatentWatch DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents Drug Patent Expirations for May 14 2013 Tradename Applicant Generic Name Patent Expiration DEPOCYT Pacira Pharms Inc cytarabine May 14, 2013 ZOMIG Astrazeneca zolmitriptan read more
-
Contributor: Yali Friedman
Contributor: 05/14/2013 12:00:00 AM EDT
Bowman v. Monsanto Supreme Court Decision for GM Seeds Patents, Licensing Copyright © thinkBiotech This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. read more
-
Contributor: Yali Friedman
Contributor: 05/13/2013 12:00:00 AM EDT
Drug Patent Expirations for May 13 2013 Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.com/innovation to see the latest expirations Advertise here This newsletter is a free service of DrugPatentWatch DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents Drug Patent Expirations for May 13 2013 Tradename Applicant Generic Name Patent Expiration ZAVESCA Actelion Pharms Ltd miglustat May 13, 2013 *Drugs may be covered by read more
-
Contributor: Yali Friedman
Contributor: 05/13/2013 12:00:00 AM EDT
Drug Patent Expirations in May 2013 Copyright © thinkBiotech Drug Patent Expirations for May 2013 Tradename Applicant Generic Name Patent Number Patent Expiration HUMALOG PEN Lilly insulin lispro recombinant 5,514,646 May 7, 2013 GEMZAR Lilly gemcitabine hydrochloride 5,464,826*PED May 7, 2013 HUMALOG MIX 50. read more
-
Contributor: Yali Friedman
Contributor: 05/10/2013 12:00:00 AM EDT
Introducing BiologicPatentWatch: Biotechnology Industry Competitive Intelligence Copyright © thinkBiotech BiologicPatentWatch concentrates deep knowledge on biologic drugs from more than 60 biotechnology companies, including more than 2,800 active and expired US patents and 41,000 patents spanning 91 international patent offices. read more
-
Contributor: Yali Friedman
Contributor: 05/07/2013 12:00:00 AM EDT
Drug Patent Expirations for May 7 2013 Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.com/innovation to see the latest expirations Advertise here This newsletter is a free service of DrugPatentWatch DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents Drug Patent Expirations for May 7 2013 Tradename Applicant Generic Name Patent Expiration GEMZAR Lilly gemcitabine hydrochloride May 7, 2013 HUMALOG Lilly insulin lispro read more
-
Contributor: Yali Friedman
Contributor: 05/07/2013 12:00:00 AM EDT
Marketspace: Leading biotechnology players, 2002–08: Key products, indications and technologies Copyright © thinkBiotech This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology Marketspace: Leading biotechnology players, 2002–08: Key products, indications and technologies Go to paper ABSTRACT: For the full year 2002, the top ten biotechnology houses generated combined revenues (= royalties/licensing income + ethical or product sales; product sales includes both diagnostic and prescription drugs) of US$15. read more
| 1000 blog results |
|
-
Artwork Matters:
Making it Happen: Design of Effective Change Management Programmes for Artwork Improvement: read more
Packaging and Labelling | change management | Artwork Improvement Programmes
-
On Drug Design - Personal reflections on the challenging tasks in drug discovery:
Searching for E.T. in Space and Drugs in the Cloud: A long time ago, in the state of Denmark, something unusual was going on. read more
Cloud computing | drug design | distributed computing
-
DIA Annual Meeting 2013 Preview: Necessity, they say, is the mother of invention. The... read more
DIA | Drug Information Association
-
5 Most Exciting Epigenetic Trials: Epigenetics has been at the forefront of genetic... read more
epigenetics | clinical trials | drug development




Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!